Plenary Session
Plenary Session 2: State-of-the-Art technologies 1

Thursday October 23, 2025 | 11:00 to 12:30
Room: Main Hall
Track: N/A

Presentations

Dr. Takeshi Saito, United States
Hepatocyte‑intrinsic, self‑assembling secretome defines the tissue microenvironment

Dr. Ryotaro Hashizume, Japan
CRISPR/Cas9 technology: a potential therapeutic approach for targeting the supernumerary chromosome in Down syndrome

Email: info@ctrms2025.org
514-874-1717